CVEvulnerability

CVE-2025-0416

8.9 HIGH Published 2025-04-01 Modified 2026-08-26 Official page ↗
Status
Deferred
Published
2025-04-01
Last modified
2026-08-26
Assigner
db4dfee8-a97e-4877-bfae-eba6d14a2166
CVSS 4.0 (db4dfee8-a97e-4877-bfae-eba6d14a2166)
8.9 HIGH — CVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:H/U:Amber
Weaknesses
CWE-250

Description

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.

Related

Weakness · CWE (1)

  • CWE-250 Execution with Unnecessary Privileges weakness

References